-
Je něco špatně v tomto záznamu ?
Hypomethylating drugs efficiently decrease cytosine methylation in telomeric DNA and activate telomerase without affecting telomere lengths in tobacco cells
E. Majerová, M. Fojtová, I. Mozgová, M. Bittová, J. Fajkus,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2010-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- adenin analogy a deriváty farmakologie MeSH
- aktivace enzymů účinky léků MeSH
- cytidin analogy a deriváty farmakologie MeSH
- DNA rostlinná chemie účinky léků MeSH
- epigeneze genetická MeSH
- genetická transkripce účinky léků MeSH
- kultivované buňky MeSH
- metylace DNA účinky léků MeSH
- nukleozomy účinky léků fyziologie MeSH
- rostlinné proteiny genetika metabolismus MeSH
- tabák cytologie účinky léků genetika metabolismus MeSH
- telomerasa metabolismus MeSH
- telomery chemie účinky léků metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Telomere homeostasis is regulated at multiple levels, including the local chromatin structure of telomeres and subtelomeres. Recent reports demonstrated that a decrease in repressive chromatin marks, such as levels of cytosine methylation in subtelomeric regions, results in telomere elongation in mouse cells. Here we show that a considerable fraction of cytosines is methylated not only in subtelomeric, but also in telomeric DNA of tobacco BY-2 cells. Drug-induced hypomethylation (demonstrated at subtelomeric, telomeric, and global DNA levels) results in activation of telomerase. However, in contrast to mouse cells, the decrease in 5-methylcytosine levels and upregulation of telomerase do not result in any changes of telomere lengths. These results demonstrate the involvement of epigenetic mechanisms in the multilevel process of regulation of telomerase activity in plant cells and, at the same time, they indicate that changes in telomerase activity can be overridden by other factors governing telomere length stability.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028094
- 003
- CZ-PrNML
- 005
- 20121210110438.0
- 007
- ta
- 008
- 120817e20110825ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11103-011-9816-7 $2 doi
- 035 __
- $a (PubMed)21866390
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Majerová, Eva $u Department of Functional Genomics and Proteomics, Faculty of Science and Central European Institute of Technology, Masaryk University, Kamenice 5, Brno, Czech Republic.
- 245 10
- $a Hypomethylating drugs efficiently decrease cytosine methylation in telomeric DNA and activate telomerase without affecting telomere lengths in tobacco cells / $c E. Majerová, M. Fojtová, I. Mozgová, M. Bittová, J. Fajkus,
- 520 9_
- $a Telomere homeostasis is regulated at multiple levels, including the local chromatin structure of telomeres and subtelomeres. Recent reports demonstrated that a decrease in repressive chromatin marks, such as levels of cytosine methylation in subtelomeric regions, results in telomere elongation in mouse cells. Here we show that a considerable fraction of cytosines is methylated not only in subtelomeric, but also in telomeric DNA of tobacco BY-2 cells. Drug-induced hypomethylation (demonstrated at subtelomeric, telomeric, and global DNA levels) results in activation of telomerase. However, in contrast to mouse cells, the decrease in 5-methylcytosine levels and upregulation of telomerase do not result in any changes of telomere lengths. These results demonstrate the involvement of epigenetic mechanisms in the multilevel process of regulation of telomerase activity in plant cells and, at the same time, they indicate that changes in telomerase activity can be overridden by other factors governing telomere length stability.
- 650 _2
- $a adenin $x analogy a deriváty $x farmakologie $7 D000225
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a cytidin $x analogy a deriváty $x farmakologie $7 D003562
- 650 _2
- $a metylace DNA $x účinky léků $7 D019175
- 650 _2
- $a DNA rostlinná $x chemie $x účinky léků $7 D018744
- 650 _2
- $a aktivace enzymů $x účinky léků $7 D004789
- 650 _2
- $a epigeneze genetická $7 D044127
- 650 _2
- $a nukleozomy $x účinky léků $x fyziologie $7 D009707
- 650 _2
- $a rostlinné proteiny $x genetika $x metabolismus $7 D010940
- 650 _2
- $a telomerasa $x metabolismus $7 D019098
- 650 _2
- $a telomery $x chemie $x účinky léků $x metabolismus $7 D016615
- 650 _2
- $a tabák $x cytologie $x účinky léků $x genetika $x metabolismus $7 D014026
- 650 _2
- $a genetická transkripce $x účinky léků $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fojtová, Miloslava
- 700 1_
- $a Mozgová, Iva
- 700 1_
- $a Bittová, Miroslava
- 700 1_
- $a Fajkus, Jiří
- 773 0_
- $w MED00006562 $t Plant molecular biology $x 1573-5028 $g Roč. 77, č. 4-5 (20110825), s. 371-80
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21866390 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210110515 $b ABA008
- 999 __
- $a ok $b bmc $g 950136 $s 785440
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 77 $c 4-5 $d 371-80 $e 20110825 $i 1573-5028 $m Plant molecular biology $n Plant Mol Biol $x MED00006562
- LZP __
- $a Pubmed-20120817/11/04